Sheela Nagarkoti

Sheela Nagarkoti

Auto-generated profile, based on publicly available information

Sheela Nagarkoti

Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2019 in Inflammation
Verified
Journal Article
Closed access
PDF file
SNSheela Nagarkoti
Sheela Nagarkoti
MDMegha Dubey
Megha Dubey
SSSamreen Sadaf
Samreen Sadaf
Deepika AwasthiDeepika Awasthi
Deepika Awasthi
TCTulika Chandra
Tulika Chandra
MDMadhu Dikshit
Madhu Dikshit

19 June 2026 in Antioxidants
Verified
Journal Article
Open access
PDF file
SYShikha Yadav
Shikha Yadav
RRRajagopalan Rajagopal
Rajagopalan Rajagopal
SVSudhahar Varadarajan
Sudhahar Varadarajan
SNSheela Nagarkoti
Sheela Nagarkoti
ADArchita Das
Archita Das
Masuko Ushio-FukaiMasuko Ushio-Fukai
Masuko Ushio-Fukai
Reparative macrophage polarization and macrophage-derived reactive oxygen species (ROS) are required for ischemia-induced revascularization in peripheral artery disease (PAD). Our previous study showed that mitochondrial fission protein dynamin-related protein 1 (DRP1) promotes reparative polarization and metabolic reprogramming in macrophages and post-ischemic neovascularization. However, the redox-dependent mechanism governing DRP1 activation in this context remains elusive. Here, using a mouse hindlimb ischemia (HLI) model of PAD, we identify cysteine sulfenylation (CysOH) of DRP1 as a critical redox modification induced in ischemic bone marrow (BM)-derived cells. BM chimeric mice reconstituted with CRISPR/Cas9-generated “redox-dead” DRP1-C631A knock-in mutant (Drp1C/A) BM exhibited markedly reduced limb perfusion recovery and CD31+ capillary density in ischemic muscles following HLI. These defects were associated with enhanced Ly6G+ neutrophil accumulation, pro-inflammatory F4/80+CD80+ M1-like macrophages and reduced anti-inflammatory F4/80+CD206+ M2-like macrophages in ischemic muscle. Mechanistically, using an in vitro PAD model, hypoxia serum starvation (HSS) rapidly induced NADPH oxidase 2-dependent cytosolic ROS production and DRP1-CysOH formation in wild-type macrophages. In contrast, Drp1C/A macrophages failed to undergo DRP1-CysOH-dependent mitochondrial fission under HSS, resulting in aberrant metabolic reprogramming characterized by enhanced glycolysis and mitochondrial ROS, pro-inflammatory p-NF-κB and M1-genes, and suppressed anti-inflammatory p-AMPK, efferocytosis and M2-genes. Thus, our findings establish DRP1 sulfenylation as a previously unrecognized redox-sensing mechanism that links ischemia-induced ROS to reparative macrophage reprogramming and revascularization, identifying a novel therapeutic target for PAD.